Developer docs
API playgroundTry for free, no card

Search company profiles

Sterling Accuris

Full company profile

uuid0002aor

Namestring
Sterling Accuris
Legal namestring
Sterling Accuris Wellness Private Limited
Company typeenum
Private
Founded yearint
2015
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersAhmedabad, India
HQ citystring
Ahmedabad
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices12 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pathology diagnostics, clinical laboratory services, home sample collection, health checkup packages, genetic testing services
Industry1 code
1Blood Bank/Transfusion Medicine LIS
CodeHLACAMAEPrimaryYes
Product category
Diagnostic Laboratory Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1Diagnostic Testing Services
TypeTransaction Fee
Description

Pathology and diagnostic testing services offered to individual patients and healthcare providers, including blood tests, urine tests, and specialized diagnostic examinations across multiple specialties.

sterlingaccuris.com
2Health Packages
TypeTransaction Fee
Description

Pre-defined health checkup packages (B+ Health Packages) offering bundled diagnostic tests at discounted rates compared to individual test pricing.

sterlingaccuris.com
3Membership Program
TypeSubscription Recurring
Description

B+ve membership card offering lifetime discounts up to 25% on tests, 10% off on packages, and reward points on bookings.

sterlingaccuris.com
4Franchise Revenue
TypeLicensing Royalties
Description

Franchise partnerships where collection centers operate under Sterling Accuris brand, contributing to network expansion and brand presence.

sterlingaccuris.com
5Corporate Health Services
TypeProfessional Services
Description

B2B employee health checkup programs for corporate clients including on-site screenings, customized packages, and annual health assessments.

sterlingaccuris.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain
Pricing details3 tiers
1Individual diagnostic tests with unit-based pricing
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Tests range from INR 50 (Fasting Blood Sugar) to INR 800+ (Vitamin B12), with most common tests like CBC at INR 200-350, Lipid Profile at INR 550-750, and Thyroid Function Test at INR 500-600.

sterlingaccuris.com
2Franchise partnership investment
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Minimum investment around INR 2.5-3 lakhs with approximately 200-250 sq. ft. area required at ground floor with toilet facility.

sterlingaccuris.com
3B+ve Membership Card
ModelSubscriptionBilling cadenceAnnual
Notes

Lifetime membership offering up to 25% off on tests, 10% off on B+ve packages, and 10 reward points on every booking (1 Point = INR 1). 100 points on signup.

sterlingaccuris.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 record
1PanGenomics
Description

A molecular and genetic laboratory subsidiary offering genetic testing and counselling services including clinical genetic testing for over 300 different genetic conditions, COVID-19 RT-PCR testing, and genetic counselling. Founded in 2014 and NABL accredited.

sterlingaccuris.com
Core offering1 text field

Sterling Accuris is a pathology-focused diagnostic lab chain offering 2,000+ diagnostic tests, pre-defined B+ Health Packages, home sample collection (including Accuris Express 30-minute service), and genetic/molecular diagnostics through its PanGenomics subsidiary. Services are delivered via 250+ owned and franchised collection centers, NABL accredited laboratories, and a digital booking platform serving individual patients and corporate clients across multiple Indian states.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • First medical lab in India to achieve GCLP compliance (Good Clinical Laboratory Practice)
+1 more record
Product and service1 record
1Diagnostic Testing Services
CategoryDiagnostic Laboratory Services
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierStrategicTypeOthers
Description

Ahmedabad-based diagnostic lab acquired in June 2023 to expand Sterling's presence and offerings in Gujarat. The acquisition enhances test menu and technological capabilities leveraging VIP Labs' local expertise.

2Vaibhav Analytical Services
Strategic tierStrategicTypeOthers
Description

Leading provider of analytical testing services based in Ahmedabad, acquired in December 2023 as part of Sterling Accuris' expansion strategy.

sterlingaccuris.com
3G-Auto and SMILE IIM Ahmedabad
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaborative health education and screenings camp for auto drivers conducted in August 2022, promoting community health awareness in partnership with G-Auto and SMILE IIM Ahmedabad.

sterlingaccuris.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

NABL accredited national laboratory dedicated to kidney stone analysis, the only lab in India performing Integrated Stone analysis and 24-hour Urine Metabolic Profile (Litho-Risk). Provides specialized diagnostic services under partnership.

Strategic tierCoreTypeOthers
Description

Molecular and genetic laboratory founded in 2014, NABL accredited subsidiary offering over 300 genetic conditions tests using technologies including NGS, PCR, FISH, and genetic counselling. ICMR authorized for COVID-19 RT-PCR testing.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

One of India's largest diagnostic chains with an extensive national network. Directly competes on pathology test menu, hospital partnerships, and preventive health packages with similar franchise and B2C models.

TypeBroad incumbent
Description

Diagnostic arm of Apollo Hospitals, one of India's largest hospital chains. Offers routine and advanced pathology with hospital integration and pan-India reach, competing broadly in the same space.

TypeDirect peer
Description

National diagnostic chain with strong presence in western and southern India. Overlaps with Sterling Accuris on routine and specialty pathology, corporate wellness, and home collection services.

TypeDirect peer
Description

Multi-state diagnostic chain with strong focus on advanced and molecular diagnostics including genomics. Highly comparable on geographic expansion through acquisitions and specialty/genetic testing capabilities.

TypeRegional player
Description

South India-focused diagnostic chain with deep presence in Andhra Pradesh and Telangana. Comparable on integrated lab-network model with NABL-accredited facilities and home collection services.

TypeRegional player
Description

West India-focused diagnostic chain headquartered in Mumbai with strong Maharashtra presence. Comparable on regional B2C pathology, corporate wellness, and home collection in overlapping geographies.

TypeDirect peer
Description

Pan-India preventive diagnostics chain offering affordable health packages via a franchisee/aggregator network. Closely comparable on package-led B2B2C and franchise distribution model.

TypeDirect peer
Description

India's largest national pathology and diagnostic lab chain with pan-India presence. Direct competitor on routine and specialized tests, B2C walk-ins, and home collection services across tier-1 to tier-3 cities.

TypeEmerging player
Description

Digital health platform offering online diagnostic test booking, home sample collection, and aggregator partnerships with labs. Competes with Sterling Accuris's direct-to-consumer digital funnel and home collection.

TypeEmerging player
Description

Specialized diagnostics chain with focus on oncology, molecular, and genetic testing. Comparable on specialty/molecular testing depth similar to Sterling Accuris's PanGenomics subsidiary.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration7 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sterling Accuris

Diagnostic Laboratory Servicessterlingaccuris.com

Sterling Accuris firmographics

Firmographics
Name
Sterling Accuris
Legal name
Sterling Accuris Wellness Private Limited
Website
https://sterlingaccuris.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
1,001–5,000 employees
Ownership category
akta.pro rank

Sterling Accuris industry classification

Industry
Product category
Diagnostic Laboratory Services
akta.pro primary industry
Blood Bank/Transfusion Medicine LIS (HLACAMAE)

Keywords

  • Pathology diagnostics
  • Clinical laboratory services
  • Home sample collection
  • Health checkup packages
  • Genetic testing services

Where Sterling Accuris is headquartered

Location

Headquarters

HQ city
Ahmedabad
HQ country
India
HQ region
Asia

Offices12 records

Markets served

Sterling Accuris business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

  1. Diagnostic Testing Services: Pathology and diagnostic testing services offered to individual patients and healthcare providers, including blood tests, urine tests, and specialized diagnostic examinations across multiple specialties.
  2. Health Packages: Pre-defined health checkup packages (B+ Health Packages) offering bundled diagnostic tests at discounted rates compared to individual test pricing.
  3. Membership Program: B+ve membership card offering lifetime discounts up to 25% on tests, 10% off on packages, and reward points on bookings.
  4. Franchise Revenue: Franchise partnerships where collection centers operate under Sterling Accuris brand, contributing to network expansion and brand presence.
  5. Corporate Health Services: B2B employee health checkup programs for corporate clients including on-site screenings, customized packages, and annual health assessments.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goIndividual diagnostic tests with unit-based pricing
One time/ perpetual licenseMulti-year contractFranchise partnership investment
SubscriptionAnnualB+ve Membership Card

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

Sterling Accuris product offering

Product offering

Core offering

Sterling Accuris is a pathology-focused diagnostic lab chain offering 2,000+ diagnostic tests, pre-defined B+ Health Packages, home sample collection (including Accuris Express 30-minute service), and genetic/molecular diagnostics through its PanGenomics subsidiary. Services are delivered via 250+ owned and franchised collection centers, NABL accredited laboratories, and a digital booking platform serving individual patients and corporate clients across multiple Indian states.

Differentiator

Problem solved

Functional benefit

Brands

  • PanGenomics: A molecular and genetic laboratory subsidiary offering genetic testing and counselling services including clinical genetic testing for over 300 different genetic conditions, COVID-19 RT-PCR testing, and genetic counselling. Founded in 2014 and NABL accredited.

Products and services

  • Diagnostic Testing Services

Quantifiable outcome

  • First medical lab in India to achieve GCLP compliance (Good Clinical Laboratory Practice)
  • +1 more outcomes

Companies that use Sterling Accuris

Customer profile

Named customers7 records

Segments4 records

Ideal customer profiles3 records

Sterling Accuris technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration7 records

Feature4 records

Sterling Accuris partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered strategic, minor and core.

  • VIP LabsstrategicOthersAhmedabad-based diagnostic lab acquired in June 2023 to expand Sterling's presence and offerings in Gujarat. The acquisition enhances test menu and technological capabilities leveraging VIP Labs' local expertise.
  • Vaibhav Analytical ServicesstrategicOthersLeading provider of analytical testing services based in Ahmedabad, acquired in December 2023 as part of Sterling Accuris' expansion strategy.
  • G-Auto and SMILE IIM AhmedabadminorStrategic or Co-development PartnerCollaborative health education and screenings camp for auto drivers conducted in August 2022, promoting community health awareness in partnership with G-Auto and SMILE IIM Ahmedabad.
  • UrolabcoreStrategic or Co-development PartnerNABL accredited national laboratory dedicated to kidney stone analysis, the only lab in India performing Integrated Stone analysis and 24-hour Urine Metabolic Profile (Litho-Risk). Provides specialized diagnostic services under partnership.
  • PanGenomicscoreOthersMolecular and genetic laboratory founded in 2014, NABL accredited subsidiary offering over 300 genetic conditions tests using technologies including NGS, PCR, FISH, and genetic counselling. ICMR authorized for COVID-19 RT-PCR testing.

Scale indicators9 records

Recent moves8 records

Expansion highlights6 records

Sterling Accuris competitors and assessment

Company assessment

Direct peers

  • SRL Diagnostics: One of India's largest diagnostic chains with an extensive national network. Directly competes on pathology test menu, hospital partnerships, and preventive health packages with similar franchise and B2C models.
  • Metropolis Healthcare: National diagnostic chain with strong presence in western and southern India. Overlaps with Sterling Accuris on routine and specialty pathology, corporate wellness, and home collection services.
  • Neuberg Diagnostics: Multi-state diagnostic chain with strong focus on advanced and molecular diagnostics including genomics. Highly comparable on geographic expansion through acquisitions and specialty/genetic testing capabilities.
  • Thyrocare Technologies: Pan-India preventive diagnostics chain offering affordable health packages via a franchisee/aggregator network. Closely comparable on package-led B2B2C and franchise distribution model.
  • Dr. Lal PathLabs: India's largest national pathology and diagnostic lab chain with pan-India presence. Direct competitor on routine and specialized tests, B2C walk-ins, and home collection services across tier-1 to tier-3 cities.

Broad incumbents

  • Apollo Diagnostics: Diagnostic arm of Apollo Hospitals, one of India's largest hospital chains. Offers routine and advanced pathology with hospital integration and pan-India reach, competing broadly in the same space.

Regional players

  • Vijaya Diagnostic Centre: South India-focused diagnostic chain with deep presence in Andhra Pradesh and Telangana. Comparable on integrated lab-network model with NABL-accredited facilities and home collection services.
  • Suburban Diagnostics: West India-focused diagnostic chain headquartered in Mumbai with strong Maharashtra presence. Comparable on regional B2C pathology, corporate wellness, and home collection in overlapping geographies.

Emerging players

  • Tata 1mg: Digital health platform offering online diagnostic test booking, home sample collection, and aggregator partnerships with labs. Competes with Sterling Accuris's direct-to-consumer digital funnel and home collection.
  • Oncquest Laboratories: Specialized diagnostics chain with focus on oncology, molecular, and genetic testing. Comparable on specialty/molecular testing depth similar to Sterling Accuris's PanGenomics subsidiary.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Sterling Accuris social profiles

Digital presence

Sterling Accuris financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sterling Accuris leadership team

Management profile

Number of profiles

Profiles3 records

Sterling Accuris subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Sterling Accuris funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sterling Accuris M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sterling Accuris

What does Sterling Accuris do?

Sterling Accuris is a pathology-focused diagnostic lab chain offering 2,000+ diagnostic tests, pre-defined B+ Health Packages, home sample collection (including Accuris Express 30-minute service), and genetic/molecular diagnostics through its PanGenomics subsidiary. Services are delivered via 250+ owned and franchised collection centers, NABL accredited laboratories, and a digital booking platform serving individual patients and corporate clients across multiple Indian states.

Is Sterling Accuris a public or private company?

Sterling Accuris is a private company. It is classified as private equity controlled and is currently operating.

When was Sterling Accuris founded?

Sterling Accuris was founded in 2015. It employs 1,001 to 5,000 people.

Where is Sterling Accuris based?

Sterling Accuris is headquartered in Ahmedabad, India, in the Asia region.

How does Sterling Accuris make money?

Five revenue lines are on record. Diagnostic Testing Services are the primary driver. The others are health Packages, membership Program, franchise Revenue and corporate Health Services.

Who are Sterling Accuris's main competitors?

Direct peers on record are SRL Diagnostics, Metropolis Healthcare, Neuberg Diagnostics, Thyrocare Technologies and Dr. Lal PathLabs. Apollo Diagnostics is listed as a broad incumbent. Regional players are Vijaya Diagnostic Centre and Suburban Diagnostics. Emerging players are Tata 1mg and Oncquest Laboratories.

Does Sterling Accuris have an API?

No public API is recorded for Sterling Accuris.

What industry is Sterling Accuris in?

Sterling Accuris's product category is Diagnostic Laboratory Services. Its primary akta.pro industry code is HLACAMAE, Blood Bank/Transfusion Medicine LIS.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EntrackrMorgan Stanley-backed Sterling Accuris reports Rs 231 Cr revenue in FY26; losses widen 38%Sterling Accuris reported revenue of Rs 230.7 crore in FY26, up 16% year-on-year, but its net loss widened 38% to Rs 32 crore. The Ahmedabad-based diagnostics firm's total expenses rose 17.5% to Rs 259.5 crore, while EBITDA remained positive at Rs 2.8 crore.The TribuneSterling Accuris Launches ‘Accuris Express’, Offering 30-Minute Home Sample Collection in AhmedabadSterling Accuris has launched Accuris Express, a new service offering 30-minute home diagnostic sample collection in Ahmedabad, Gujarat, with plans for phased expansion across the state. The service allows users to book eligible tests through the company's website and app, with priority home sample collection by trained phlebotomists. Sterling Accuris, established in 2015 and operating over 90 processing laboratories and more than 300 collection centres across Gujarat, developed the service to address growing consumer demand for faster, more convenient diagnostic testing.The TribuneSterling Accuris Launches 'Accuris Express', Offering 30-Minute Home Sample Collection in AhmedabadSterling Accuris has launched 'Accuris Express', a new service offering home diagnostic sample collection within 30 minutes in Ahmedabad, with plans for phased expansion across Gujarat. The service enables users to book eligible tests through the company's website and app, with priority home sample collection by trained phlebotomists. Established in 2015, Sterling Accuris operates over 90 processing laboratories and more than 300 collection centres across Gujarat, with a portfolio of over 2,000 diagnostic tests.DevdiscourseSterling Accuris Launches 'Accuris Express', Offering 30-Minute Home Sample Collection in AhmedabadSterling Accuris has launched "Accuris Express," a home diagnostic sample collection service in Ahmedabad that promises collection within 30 minutes, with phased expansion planned across Gujarat. The service combines rapid home sample collection with Sterling Accuris' existing laboratory standards, targeting consumers seeking convenience including elderly patients, working professionals, and families with young children. The launch reflects a broader shift in healthcare delivery toward on-demand, doorstep services that prioritise speed and accessibility.Ani NewsSterling Accuris Launches 'Accuris Express', Offering 30-Minute Home Sample Collection in AhmedabadSterling Accuris launched 'Accuris Express', a new service offering 30-minute home sample collection for diagnostic testing in Ahmedabad, Gujarat. The service enables users to book eligible tests through the Sterling Accuris website and app, with trained phlebotomists arriving at homes for priority sample collection. The company plans a phased expansion across Gujarat after the initial rollout in Ahmedabad.YourStorySterling Accuris acquires Gujarat Pathology Lab to expand Ahmedabad networkSterling Accuris Diagnostics announced the acquisition of Gujarat Pathology Laboratory, a pathology service provider based in Ahmedabad, marking the company's fourth acquisition in two years. The deal will expand Sterling Accuris' operational footprint in Ahmedabad by adding eight laboratories and over 20 collection centres to its existing network of 75 laboratories and 300 collection centres across India. The acquisition aligns with a broader trend of consolidation in India's diagnostics sector, as larger players seek to strengthen regional presence and tap into the projected 14% CAGR growth of the pathology segment between 2025 and 2030.BioSpectrum IndiaSterling Accuris buys Gujarat Pathology Laboratory and Diagnostic CentreSterling Accuris Diagnostics has announced the acquisition of Gujarat & Maha Gujarat Pathology Laboratories, a leading pathology service provider in Ahmedabad that has been operating since 1998. The acquisition will expand Sterling Accuris's network across Ahmedabad, adding 8 laboratories and more than 20 collection centres to its existing presence in Gujarat, Rajasthan, and Madhya Pradesh. The deal aims to leverage Gujarat Pathology Laboratory's B2C strengths and Sterling Accuris's high-end technology to enhance diagnostic service reach and quality across the region.VCCirclePE-backed Sterling Accuris snaps up diagnostics firmSterling Accuris Wellness Pvt Ltd has acquired Ahmedabad-based pathology service provider VIP Labs to strengthen its presence in Gujarat and expand its geographical reach. The acquisition allows Sterling to merge resources and offer VIP Labs patrons access to high-end testing menus, although specific financial details of the transaction were not disclosed.MintSterling Accuris Wellness raises Rs250 cr from Morgan Stanley PE Asia | Company Business NewsSterling Accuris Wellness Pvt Ltd has signed an agreement to raise Rs250 crore ($34 million) in equity capital from a fund managed by Morgan Stanley Private Equity Asia. The diagnostic lab chain plans to use the proceeds to expand its network of approximately 150 labs and enter new geographic markets across India. Veda Corporate Advisors acted as the financial advisor for the transaction.